1170 related articles for article (PubMed ID: 15949105)
41. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
42. Systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Standring R; Wang Y
Laryngoscope; 2015 Jan; 125(1):203-8. PubMed ID: 24913022
[TBL] [Abstract][Full Text] [Related]
43. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
Shojaku H; Watanabe Y; Mineta H; Aoki M; Tsubota M; Watanabe K; Goto F; Shigeno K
Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
[TBL] [Abstract][Full Text] [Related]
44. [Long-term efficacy of triple semicircular canal occlusion in the treatment of intractable Meniere's disease].
Zhang D; Fan Z; Han Y; Li Y; Wang H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):733-7. PubMed ID: 26696345
[TBL] [Abstract][Full Text] [Related]
45. Clinical diagnosis of Ménière's disease: how useful are the American Academy of Otolaryngology Head and Neck Surgery Committee on Hearing and Equilibrium guidelines?
Stapleton E; Mills R
J Laryngol Otol; 2008 Aug; 122(8):773-9. PubMed ID: 17931446
[TBL] [Abstract][Full Text] [Related]
46. Trends in the diagnosis and the management of Meniere's disease: results of a survey.
Kim HH; Wiet RJ; Battista RA
Otolaryngol Head Neck Surg; 2005 May; 132(5):722-6. PubMed ID: 15886625
[TBL] [Abstract][Full Text] [Related]
47. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
Thomsen J; Sass K; Odkvist L; Arlinger S
Otol Neurotol; 2005 Jan; 26(1):68-73. PubMed ID: 15699722
[TBL] [Abstract][Full Text] [Related]
48. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
Schmerber S; Dumas G; Morel N; Chahine K; Karkas A
Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
[TBL] [Abstract][Full Text] [Related]
49. Comparison of second-echelon treatments for Ménière's disease.
Basura GJ; Lin GC; Telian SA
JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):754-61. PubMed ID: 25057891
[TBL] [Abstract][Full Text] [Related]
50. Posterior fossa vestibular neurotomy as primary surgical treatment of Menière's disease: a re-evaluation.
Pareschi R; Destito D; Falco Raucci A; Righini S; Colombo S
J Laryngol Otol; 2002 Aug; 116(8):593-6. PubMed ID: 12389685
[TBL] [Abstract][Full Text] [Related]
51. Retrosigmoid approach for vestibular neurectomy in Meniere's disease.
Perez R; Ducati A; Garbossa D; Benech F; Fontanella MM; Canale A; Albera R
Acta Neurochir (Wien); 2005 Apr; 147(4):401-4; discussion 404. PubMed ID: 15618995
[TBL] [Abstract][Full Text] [Related]
52. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
[TBL] [Abstract][Full Text] [Related]
53. Surgical management of Meniere's disease in the era of gentamicin.
Kaylie DM; Jackson CG; Gardner EK
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):443-50. PubMed ID: 15746859
[TBL] [Abstract][Full Text] [Related]
54. Transtympanic steroids for Ménière's disease.
Herraiz C; Plaza G; Aparicio JM; Gallego I; Marcos S; Ruiz C
Otol Neurotol; 2010 Jan; 31(1):162-7. PubMed ID: 19924013
[TBL] [Abstract][Full Text] [Related]
55. Visualization of endolymphatic hydrops and correlation with audio-vestibular functional testing in patients with definite Meniere's disease.
Seo YJ; Kim J; Choi JY; Lee WS
Auris Nasus Larynx; 2013 Apr; 40(2):167-72. PubMed ID: 22867525
[TBL] [Abstract][Full Text] [Related]
56. Triple Canal Occlusion for the Treatment of Intractable Menière's Disease.
Gill C; Muzaffar J; Kumar R; Irving R
Otol Neurotol; 2021 Jan; 42(1):116-120. PubMed ID: 33201079
[TBL] [Abstract][Full Text] [Related]
57. Oral steroid treatment for hearing improvement in Ménière's disease and endolymphatic hydrops.
Fisher LM; Derebery MJ; Friedman RA
Otol Neurotol; 2012 Dec; 33(9):1685-91. PubMed ID: 23047260
[TBL] [Abstract][Full Text] [Related]
58. Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.
She W; Lv L; Du X; Li H; Dai Y; Lu L; Ma X; Chen F
J Laryngol Otol; 2015 Mar; 129(3):232-7. PubMed ID: 25655232
[TBL] [Abstract][Full Text] [Related]
59. Intratympanic gentamicin therapy for Ménière's disease.
Hirsch BE; Kamerer DB
Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
[TBL] [Abstract][Full Text] [Related]
60. Tenotomy of the middle ear muscles causes a dramatic reduction in vertigo attacks and improves audiological function in definite Meniere's disease.
Loader B; Beicht D; Hamzavi JS; Franz P
Acta Otolaryngol; 2012 May; 132(5):491-7. PubMed ID: 22201453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
